Excess nitric oxide production by one enzyme has been tied to human illnesses ranging from inflammation to cancer  but adequate treatments for the problem have been elusive Now  work led by scientists at The Scripps Research Institute has revealed a new method for chemically targeting this single enzyme to block troubling nitric oxide production  without limiting its beneficial production by other closely related enzymes